These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21496867)

  • 1. Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers.
    Xu HT; Yang LH; Li QC; Liu SL; Liu D; Xie XM; Wang EH
    Hum Pathol; 2011 Oct; 42(10):1491-8. PubMed ID: 21496867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
    Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
    Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage.
    Xu HT; Xie XM; Li QC; Liu SL; Dai SD; Liu Y; Wang EH
    APMIS; 2013 Feb; 121(2):111-9. PubMed ID: 23030416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression patterns and correlations of chibby, β-catenin, and DNA methyltransferase-1 and their clinicopathological significance in lung cancers.
    Xu HT; Li QC; Dai SD; Xie XM; Liu DI; Wang EH
    APMIS; 2011 Nov; 119(11):750-8. PubMed ID: 21995627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential.
    Machida Y; Ueda Y; Shimasaki M; Sato K; Sagawa M; Katsuda S; Sakuma T
    Hum Pathol; 2011 May; 42(5):669-78. PubMed ID: 21237499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIN-1 protein expression and localization in glioblastoma.
    Pećina-Slaus N; Martić TN; Kokotović T; Kusec V; Tomas D; Hrasćan R
    Coll Antropol; 2011 Jan; 35 Suppl 1():101-6. PubMed ID: 21648318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of EYA2 in non-small cell lang cancer].
    Guo JT; Ding LH; Liang CY; Zhou NK; Ye QN
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):528-31. PubMed ID: 19950702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer.
    Xu HT; Wang L; Lin D; Liu Y; Liu N; Yuan XM; Wang EH
    Am J Clin Pathol; 2006 Apr; 125(4):534-41. PubMed ID: 16627264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
    Shibahara K; Sugio K; Osaki T; Uchiumi T; Maehara Y; Kohno K; Yasumoto K; Sugimachi K; Kuwano M
    Clin Cancer Res; 2001 Oct; 7(10):3151-5. PubMed ID: 11595709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.
    Nonaka D; Fabbri A; Roz L; Mariani L; Vecchione A; Moore GW; Tavecchio L; Croce CM; Sozzi G
    Cancer Res; 2005 Feb; 65(4):1207-12. PubMed ID: 15735004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma.
    Narahashi T; Niki T; Wang T; Goto A; Matsubara D; Funata N; Fukayama M
    Histopathology; 2006 Oct; 49(4):349-57. PubMed ID: 16978197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
    Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
    Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.
    Ishii A; Suzuki M; Satomi K; Kobayashi H; Sakashita S; Kano J; Pei Y; Minami Y; Ishikawa S; Noguchi M
    Pathol Int; 2009 Sep; 59(9):623-30. PubMed ID: 19712129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of Axin and beta-catenin in non-small cell lung cancer].
    Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.